Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: AMUZA INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-09-12 to 2025-11-12
Current total value of award: $14761.25
Description: [25-015207] IN-VIVO GENE THERAPY CORE REQUIRES HIGH SPEED CENTRIFUGE IN ORDER TO PURIFICATION OF CELLS DURING PROCESSING